fillwise.fillwise.

Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Medication plan: estimated costs for a whole medication list

Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.

Prazosin HCL

Form:

12 of 12 products shown

9 general benefit · 3 listing conditions apply

Apo-Prazo · DIN 00882801 · 1 mg · tablet

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Apo-Prazo · DIN 00882801 Manufacturer: Apotex Inc.; listing date 1996-10-01 Daily cost (source): $0.5486 Health Canada: Marketed since 2025-01-23 · brand APO-PRAZO · ATC C02CA01 PRAZOSIN · form Tablet · route Oral · ingredients PRAZOSIN (PRAZOSIN HYDROCHLORIDE) 1 MG · company Apotex inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Apo-Prazo: Formulary list price $0.27 per unit (the source does not state the unit; exact figure $0.2743). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00882801)

Source record
DIN 00882801: Apo-Prazo Raw flags: chronicUseMed=Y, sec3=Y Item: 240800089; group id 347; item number 0792; lccId None; manufacturer id APX Source form: Tab; strength: 1mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2743; ministry $0.2743 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00882801 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10828
Interchangeable products
Minipress · DIN 00560952 · $0.2743 Teva-Prazosin · DIN 01934198 · $0.2743
Shortage status: resolved shortage (ended October 1, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00882801
Shortage record checked October 6, 2026

Teva-Prazosin · DIN 01934198 · 1 mg · tablet

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Teva-Prazosin · DIN 01934198 Manufacturer: Teva Canada Limited; listing date 1996-10-01 Daily cost (source): $0.5486 Health Canada: Marketed since 2011-10-20 · brand TEVA-PRAZOSIN · ATC C02CA01 PRAZOSIN · form Tablet · route Oral · ingredients PRAZOSIN (PRAZOSIN HYDROCHLORIDE) 1 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Teva-Prazosin: Formulary list price $0.27 per unit (the source does not state the unit; exact figure $0.2743). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01934198)

Source record
DIN 01934198: Teva-Prazosin Raw flags: chronicUseMed=Y, sec3=Y Item: 240800089; group id 347; item number 0792; lccId None; manufacturer id TEV Source form: Tab; strength: 1mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2743; ministry $0.2743 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01934198 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=12451
Interchangeable products
Apo-Prazo · DIN 00882801 · $0.2743 Minipress · DIN 00560952 · $0.2743
Shortage status: active shortage (reported June 10, 2026, estimated to end October 20, 2026, last updated September 25, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01934198
Shortage record checked October 6, 2026

Apo-Prazo · DIN 00882828 · 2 mg · tablet

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Apo-Prazo · DIN 00882828 Manufacturer: Apotex Inc.; listing date 1996-10-01 Daily cost (source): $0.7450 Health Canada: Marketed since 2025-01-23 · brand APO-PRAZO · ATC C02CA01 PRAZOSIN · form Tablet · route Oral · ingredients PRAZOSIN (PRAZOSIN HYDROCHLORIDE) 2 MG · company Apotex inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Apo-Prazo: Formulary list price $0.37 per unit (the source does not state the unit; exact figure $0.3725). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00882828)

Source record
DIN 00882828: Apo-Prazo Raw flags: chronicUseMed=Y, sec3=Y Item: 240800088; group id 347; item number 0793; lccId None; manufacturer id APX Source form: Tab; strength: 2mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.3725; ministry $0.3725 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00882828 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10829
Interchangeable products
Minipress · DIN 00560960 · $0.3725 Teva-Prazosin · DIN 01934201 · $0.3725
Shortage status: resolved shortage (ended January 24, 2025); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00882828
Shortage record checked October 6, 2026

Teva-Prazosin · DIN 01934201 · 2 mg · tablet

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Teva-Prazosin · DIN 01934201 Manufacturer: Teva Canada Limited; listing date 1996-10-01 Daily cost (source): $0.7450 Health Canada: Marketed since 2011-10-20 · brand TEVA-PRAZOSIN · ATC C02CA01 PRAZOSIN · form Tablet · route Oral · ingredients PRAZOSIN (PRAZOSIN HYDROCHLORIDE) 2 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Teva-Prazosin: Formulary list price $0.37 per unit (the source does not state the unit; exact figure $0.3725). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01934201)

Source record
DIN 01934201: Teva-Prazosin Raw flags: chronicUseMed=Y, sec3=Y Item: 240800088; group id 347; item number 0793; lccId None; manufacturer id TEV Source form: Tab; strength: 2mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.3725; ministry $0.3725 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01934201 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=12452
Interchangeable products
Apo-Prazo · DIN 00882828 · $0.3725 Minipress · DIN 00560960 · $0.3725
Shortage status: resolved shortage (ended November 12, 2025); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01934201
Shortage record checked October 6, 2026

Apo-Prazo · DIN 00882836 · 5 mg · tablet

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Apo-Prazo · DIN 00882836 Manufacturer: Apotex Inc.; listing date 1996-10-01 Daily cost (source): $1.0242 Health Canada: Marketed since 2025-01-23 · brand APO-PRAZO · ATC C02CA01 PRAZOSIN · form Tablet · route Oral · ingredients PRAZOSIN (PRAZOSIN HYDROCHLORIDE) 5 MG · company Apotex inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Apo-Prazo: Formulary list price $0.51 per unit (the source does not state the unit; exact figure $0.5121). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00882836)

Source record
DIN 00882836: Apo-Prazo Raw flags: chronicUseMed=Y, sec3=Y Item: 240800087; group id 347; item number 0794; lccId None; manufacturer id APX Source form: Tab; strength: 5mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.5121; ministry $0.5121 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00882836 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=10830
Interchangeable products
Minipress · DIN 00560979 · $0.5121 Teva-Prazosin · DIN 01934228 · $0.5121
Shortage status: active shortage (reported September 15, 2026, estimated to end December 4, 2026, last updated October 2, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00882836
Shortage record checked October 6, 2026

Teva-Prazosin · DIN 01934228 · 5 mg · tablet

General benefitMarketed · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Teva-Prazosin · DIN 01934228 Manufacturer: Teva Canada Limited; listing date 1996-10-01 Daily cost (source): $1.0242 Health Canada: Marketed since 2011-10-20 · brand TEVA-PRAZOSIN · ATC C02CA01 PRAZOSIN · form Tablet · route Oral · ingredients PRAZOSIN (PRAZOSIN HYDROCHLORIDE) 5 MG · company Teva canada limited · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Teva-Prazosin: Formulary list price $0.51 per unit (the source does not state the unit; exact figure $0.5121). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 01934228)

Source record
DIN 01934228: Teva-Prazosin Raw flags: chronicUseMed=Y, sec3=Y Item: 240800087; group id 347; item number 0794; lccId None; manufacturer id TEV Source form: Tab; strength: 5mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.5121; ministry $0.5121 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=01934228 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=12453
Interchangeable products
Apo-Prazo · DIN 00882836 · $0.5121 Minipress · DIN 00560979 · $0.5121
Shortage status: resolved shortage (ended November 25, 2025); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01934228
Shortage record checked October 6, 2026

Minipress · DIN 00560952 · 1 mg · tablet

General benefitDormant since February 25, 2021 · checked October 5, 2026 · What does dormant mean?
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Minipress · DIN 00560952 Manufacturer: Pfizer Canada Inc.; listing date 1996-10-01 Daily cost (source): $0.5486 Health Canada: Dormant since 2021-02-25 · brand MINIPRESS · ATC C02CA01 PRAZOSIN · form Tablet · route Oral · ingredients PRAZOSIN (PRAZOSIN HYDROCHLORIDE) 1 MG · company Aa pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Minipress: Formulary list price $0.27 per unit (the source does not state the unit; exact figure $0.2743). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00560952)

Source record
DIN 00560952: Minipress Raw flags: chronicUseMed=Y, sec3=Y Item: 240800089; group id 347; item number 0792; lccId None; manufacturer id PFI Source form: Tab; strength: 1mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2743; ministry $0.2743 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00560952 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5358
Interchangeable products
Apo-Prazo · DIN 00882801 · $0.2743 Teva-Prazosin · DIN 01934198 · $0.2743
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00560952
Shortage record checked October 6, 2026
Health Canada lists this DIN as Dormant since February 25, 2021 — choose a marketed DIN from the same-category list.

Minipress · DIN 00560960 · 2 mg · tablet

General benefitDormant since February 25, 2021 · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Minipress · DIN 00560960 Manufacturer: Pfizer Canada Inc.; listing date 1996-10-01 Daily cost (source): $0.7450 Health Canada: Dormant since 2021-02-25 · brand MINIPRESS · ATC C02CA01 PRAZOSIN · form Tablet · route Oral · ingredients PRAZOSIN (PRAZOSIN HYDROCHLORIDE) 2 MG · company Aa pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Minipress: Formulary list price $0.37 per unit (the source does not state the unit; exact figure $0.3725). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00560960)

Source record
DIN 00560960: Minipress Raw flags: chronicUseMed=Y, sec3=Y Item: 240800088; group id 347; item number 0793; lccId None; manufacturer id PFI Source form: Tab; strength: 2mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.3725; ministry $0.3725 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00560960 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5359
Interchangeable products
Apo-Prazo · DIN 00882828 · $0.3725 Teva-Prazosin · DIN 01934201 · $0.3725
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00560960
Shortage record checked October 6, 2026
Health Canada lists this DIN as Dormant since February 25, 2021 — choose a marketed DIN from the same-category list.

Minipress · DIN 00560979 · 5 mg · tablet

General benefitDormant since February 25, 2021 · checked October 5, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible • Then up to $6.11 per prescription Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
1 brand, same coverage
Minipress · DIN 00560979 Manufacturer: Pfizer Canada Inc.; listing date 1996-10-01 Daily cost (source): $1.0242 Health Canada: Dormant since 2021-02-25 · brand MINIPRESS · ATC C02CA01 PRAZOSIN · form Tablet · route Oral · ingredients PRAZOSIN (PRAZOSIN HYDROCHLORIDE) 5 MG · company Aa pharma inc · schedule Prescription
Re-check Health Canada status and shortages (live) · Health Canada product record

Minipress: Formulary list price $0.51 per unit (the source does not state the unit; exact figure $0.5121). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 00560979)

Source record
DIN 00560979: Minipress Raw flags: chronicUseMed=Y, sec3=Y Item: 240800087; group id 347; item number 0794; lccId None; manufacturer id PFI Source form: Tab; strength: 5mg Recorded listing: General benefit; chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.5121; ministry $0.5121 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=00560979 Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=5357
Interchangeable products
Apo-Prazo · DIN 00882836 · $0.5121 Teva-Prazosin · DIN 01934228 · $0.5121
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00560979
Shortage record checked October 6, 2026
Health Canada lists this DIN as Dormant since February 25, 2021 — choose a marketed DIN from the same-category list.

Prazosin Hydrochloride Capsules, USP · PIN 09858281 · 1 mg · capsule

Temporary benefitOntario PIN; no Health Canada record under this code
StatusTemporary benefit
Write on scriptcheck temporary-benefit rules below
Patient paysNot paid by ODB 65 and over; see alternatives

No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN. Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp

Check Health Canada brand search
No interchangeable product listed in the Ontario extract
Prazosin Hydrochloride Capsules, USP · DIN 09858281 Manufacturer: Sterimax Inc.; listing date 2023-09-28 No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN. Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Re-check Health Canada status and shortages (live)

Prazosin Hydrochloride Capsules, USP: Formulary list price $0.27 per unit (the source does not state the unit; exact figure $0.2743). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Ontario PIN; see Health Canada brand lookup · Verify on the e-Formulary ↗ (DIN 09858281)

Source record
DIN 09858281: Prazosin Hydrochloride Capsules, USP Raw flags: chronicUseMed=Y, sec3c=Y Item: 240800309; group id 347; item number 0789; lccId None; manufacturer id STE Source form: Cap; strength: 1mg Recorded listing: Temporary benefit (shortage substitute); chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.2743; ministry $0.2743 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=09858281 Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=09858281
Shortage record checked October 6, 2026

Prazosin Hydrochloride Capsules, USP · PIN 09858282 · 2 mg · capsule

Temporary benefitOntario PIN; no Health Canada record under this code
StatusTemporary benefit
Write on scriptcheck temporary-benefit rules below
Patient paysNot paid by ODB 65 and over; see alternatives

No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN. Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp

Check Health Canada brand search
No interchangeable product listed in the Ontario extract
Prazosin Hydrochloride Capsules, USP · DIN 09858282 Manufacturer: Sterimax Inc.; listing date 2023-09-28 No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN. Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Re-check Health Canada status and shortages (live)

Prazosin Hydrochloride Capsules, USP: Formulary list price $0.37 per unit (the source does not state the unit; exact figure $0.3725). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Ontario PIN; see Health Canada brand lookup · Verify on the e-Formulary ↗ (DIN 09858282)

Source record
DIN 09858282: Prazosin Hydrochloride Capsules, USP Raw flags: chronicUseMed=Y, sec3c=Y Item: 240800310; group id 347; item number 0790; lccId None; manufacturer id STE Source form: Cap; strength: 2mg Recorded listing: Temporary benefit (shortage substitute); chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.3725; ministry $0.3725 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=09858282 Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=09858282
Shortage record checked October 6, 2026

Prazosin Hydrochloride Capsules, USP · PIN 09858283 · 5 mg · capsule

Temporary benefitOntario PIN; no Health Canada record under this code
StatusTemporary benefit
Write on scriptcheck temporary-benefit rules below
Patient paysNot paid by ODB 65 and over; see alternatives

No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN. Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp

Check Health Canada brand search
No interchangeable product listed in the Ontario extract
Prazosin Hydrochloride Capsules, USP · DIN 09858283 Manufacturer: Sterimax Inc.; listing date 2023-09-28 No Health Canada record under this code: Ontario lists it under a product identification number (PIN), not a DIN. Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Re-check Health Canada status and shortages (live)

Prazosin Hydrochloride Capsules, USP: Formulary list price $0.51 per unit (the source does not state the unit; exact figure $0.5121). What the ministry pays, not the patient.

Formulary data: Ontario extract of September 22, 2026 · Ontario PIN; see Health Canada brand lookup · Verify on the e-Formulary ↗ (DIN 09858283)

Source record
DIN 09858283: Prazosin Hydrochloride Capsules, USP Raw flags: chronicUseMed=Y, sec3c=Y Item: 240800311; group id 347; item number 0791; lccId None; manufacturer id STE Source form: Cap; strength: 5mg Recorded listing: Temporary benefit (shortage substitute); chronic-use medication (100-day supply rule, dispensing-fee limit) Source prices (unrounded): $0.5121; ministry $0.5121 Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=09858283 Look up the brand's own DIN on Health Canada: https://health-products.canada.ca/dpd-bdpp/index-eng.jsp
Shortage status: no shortage or discontinuation reported (checked October 6, 2026); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=09858283
Shortage record checked October 6, 2026

Other products in the same Health Canada class (C02CA): coverage varies; not interchangeable

  • Doxazosin (Cardura-1): general benefit, not a benefit
Other drugs in the same formulary class (24:08 Hypotensive Drugs (For Diuretics See 40:28)) and how they are covered

Matched class: 24:08 Hypotensive Drugs (For Diuretics See 40:28)

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Public program routes: ODB 65 and over Covered without a code on the Ontario formulary: CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL & HYDROCHLOROTHIAZIDE, CILAZAPRIL & HYDROCHLOROTHIAZIDE, LABETALOL HCL, LOSARTAN POTASSIUM, LOSARTAN POTASSIUM & HYDROCHLOROTHIAZIDE, MINOXIDIL, OLMESARTAN MEDOXOMIL, OLMESARTAN MEDOXOMIL & HYDROCHLOROTHIAZIDE, PERINDOPRIL ERBUMINE, PERINDOPRIL ERBUMINE & INDAPAMIDE, PINDOLOL & HYDROCHLOROTHIAZIDE, TELMISARTAN, TELMISARTAN & AMLODIPINE BESYLATE, TELMISARTAN & HYDROCHLOROTHIAZIDE, VALSARTAN & HYDROCHLOROTHIAZIDE Some products covered without a code (check the product listing): ATENOLOL & CHLORTHALIDONE, BENAZEPRIL, CAPTOPRIL, CILAZAPRIL, CLONIDINE HCL, DOXAZOSIN MESYLATE, ENALAPRIL MALEATE, FELODIPINE, FOSINOPRIL SODIUM, HYDRALAZINE HCL, IRBESARTAN, IRBESARTAN & HYDROCHLOROTHIAZIDE, LISINOPRIL, LISINOPRIL & HYDROCHLOROTHIAZIDE, METHYLDOPA, NIFEDIPINE, PINDOLOL, QUINAPRIL, QUINAPRIL & HYDROCHLOROTHIAZIDE, RAMIPRIL, RAMIPRIL & HYDROCHLOROTHIAZIDE, TERAZOSIN HCL, TRANDOLAPRIL, VALSARTAN, VERAPAMIL HCL 24:08 Hypotensive Drugs (For Diuretics See 40:28)

DOXAZOSIN MESYLATE

· 12 products · Listed, not a benefit (3), General benefit (9) · strengths: 1mg, 2mg, 4mg · Tab

ATENOLOL & CHLORTHALIDONE

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 50 & 25mg, 100 & 25mg · Tab

BENAZEPRIL

· 6 products · Listed, not a benefit (3), General benefit (3) · strengths: 5mg, 10mg, 20mg · Tab

CANDESARTAN CILEXETIL

· 59 products · General benefit · strengths: 4mg, 8mg, 16mg, 32mg · Tab

CANDESARTAN CILEXETIL & HYDROCHLOROTHIAZIDE

· 21 products · General benefit · strengths: 16mg & 12.5mg, 32mg & 12.5mg, 32mg & 25mg · Tab

CAPTOPRIL

· 14 products · Limited Use, codes 707, 723 (2), Listed, not a benefit (4), General benefit (8) · strengths: 5mg/5mL, 25mg/5mL, 12.5mg, 25mg, 50mg, 100mg · Oral Sol, Tab

CILAZAPRIL

· 8 products · Listed, not a benefit (2), General benefit (6) · strengths: 1mg, 2.5mg, 5mg · Tab

CILAZAPRIL & HYDROCHLOROTHIAZIDE

· 2 products · General benefit · strengths: 5mg/12.5mg · Tab

CLONIDINE HCL

· 17 products · Off-Formulary Interchangeable, not an ODB benefit (7), Listed, not a benefit (2), General benefit (8) · strengths: 0.025mg, 0.1mg, 0.2mg · Tab

ENALAPRIL MALEATE

· 52 products · Listed, not a benefit (1), General benefit (51) · strengths: 2.5mg, 5mg, 10mg, 20mg · Tab

FELODIPINE

· 12 products · General benefit (10), Listed, not a benefit (2) · strengths: 2.5mg, 5mg, 10mg · ER Tab, SR Tab

FOSINOPRIL SODIUM

· 12 products · Listed, not a benefit (2), General benefit (10) · strengths: 10mg, 20mg · Tab Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=2026-09-22; class 24:08 and 35 more
Full class listing Related classes: 24:04 Cardiac Drugs, 24:06 Antilipemic Drugs, 24:12 Vasodilating Drugs, 24:32 Renin-Angiotensin Aldosterone Inhibitors Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USE APO-PRAZO (prazosin hydrochloride) is indicated in the treatment of mild to moderate essential hypertension. It is employed in a general treatment program in association with a thiazide diuretic and/or other antihypertensive agents as needed for proper patient response. APO-PRAZO may be tried as a sole therapy in those patients in whom treatment with other agents caused adverse effects or is inappropriate. https://pdf.hres.ca/dpd_pm/00047230.PDF PM date: August 01, 2018 Source product: APO-PRAZO; DIN 00882801; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.

Availability

Teva-Prazosin · DIN 01934198 Shortage status: active shortage (reported 2026-06-10, estimated to end 2026-10-20, last updated 2026-09-25); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=01934198

Check this DIN again

Apo-Prazo · DIN 00882836 Shortage status: active shortage (reported 2026-09-15, estimated to end 2026-12-04, last updated 2026-10-02); reports as of October 6, 2026 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00882836

Check this DIN again
Program rules and quotes
Public program routes (Ontario context; residency, health-card/OHIP requirements and enrolment must be confirmed from the quoted rules): ODB 65 and over (seniors path) Eligibility: You may qualify for the Ontario Drug Benefit (ODB) program when you turn 65 years old. (ontario.ca, August 18, 2026 ↗) Eligibility: The Ontario Drug Benefit program is for Ontario residents only and prescriptions must be filled in an Ontario pharmacy to be covered. (ontario.ca, August 18, 2026 ↗) Eligibility: Individual annual net income threshold Program year August 1, 2026 to July 31, 2027: $25,480 This applies to a senior who: does not have a spouse has a married spouse with whom they no longer live in a conjugal relationship has a spouse living in a long-term care home or community home for opportunity (ontario.ca, July 2, 2026 ↗) Eligibility: Combined annual net income requirement Program year August 1, 2026 to July 31, 2027: $42,290 This applies to a senior who has a spouse, other than a spouse described. (ontario.ca, July 2, 2026 ↗) Eligibility: See the first-year deductible table. (ontario.ca, August 18, 2026 ↗) What it pays / costs: the first $100 of total prescription costs each program year (August 1 to July 31 the following year) (ontario.ca, August 18, 2026 ↗) What it pays / costs: up to $6.11 for each prescription filled or refilled (after paying the deductible) (ontario.ca, August 18, 2026 ↗) What it pays / costs: Seniors enrolled in the Seniors Co-Payment Program have no annual deductible and a reduced co-payment of up to $2. (ontario.ca, August 18, 2026 ↗) Enrolment: "We will send you a letter about 3 months before your 65th birthday to let you know you will automatically join the Ontario Drug Benefit program on the first day of the month after you turn 65 years old." (ontario.ca, August 18, 2026 ↗) Enrolment: "To enroll in the Seniors Co-Payment Program, a senior must submit an application to that program and qualify under certain income eligibility thresholds." (ontario.ca, August 18, 2026 ↗)
First year on ODB? The deductible depends on birth month
For your first year of Ontario Drug Benefit program eligibility, depending on the month you turn 65, the deductible may be lower than $100. That’s because the amount of the deductible is based on the number of months between your official start date (the first day of the month after you turn 65) and July 31 (the last day of the Ontario Drug Benefit program year). For example, if you turned 65 on April 15, your official start date would be May 1. Counting from May 1 to July 31 your deductible for the first year would be $25. Use this chart below to see what the deductible will be in your first year:
Month you were bornAmount of first-year deductible
July$100.00
August$91.67
September$83.33
October$75.00
November$66.67
December$58.33
January$50.00
February$41.67
March$33.33
April$25.00
May$16.67
June$8.33

Ontario source · 2026-08-18

Health Canada: dormant products
Health Canada defines dormant products as: “products that were previously marketed in Canada but for which the manufacturer has suspended sale for period of at least 12 months.” (canada.ca, September 10, 2026 ↗)